These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 1011361)

  • 21. Cephaloridine serum levels in patients on maintenance haemodialysis.
    Curtis JR; Marshall MJ
    Br Med J; 1970 Apr; 2(5702):149-51. PubMed ID: 5440596
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pharmacokinetic studies of tobramycin using the continuous intravenous infusion method (author's transl)].
    Yamasaku F; Yamada H
    Jpn J Antibiot; 1981 Nov; 34(11):1429-35. PubMed ID: 7334576
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Basic and clinical evaluation of cephaloridine in obstetrics and gynecology].
    Takase Z; Ishikawa A; Shirota H; Kuwashima U; Mizutani K
    Sanfujinka No Jissai; 1967 May; 16(5):386-91. PubMed ID: 5630533
    [No Abstract]   [Full Text] [Related]  

  • 24. [Absorption and excretion of cephapirin (author's transl)].
    Morikawa A; Maruta H; Mizuno D
    Jpn J Antibiot; 1974 Apr; 27(2):182-4. PubMed ID: 4546584
    [No Abstract]   [Full Text] [Related]  

  • 25. [Renal transport and nephrotoxicity of cephaloridine (author's transl)].
    Murayama T
    Hokkaido Igaku Zasshi; 1980 Nov; 55(6):527-36. PubMed ID: 6792022
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Studies on the metabolic fate of isepamicin sulfate (HAPA-B). IV. Intramuscular, intravenous and drip intravenous administration of HAPA-B in dogs].
    Serizawa K; Shirai M; Endo S; Suzuki T; Morishita M
    Jpn J Antibiot; 1987 Jan; 40(1):220-31. PubMed ID: 3586331
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Disposition kinetics and dosage of cephaloridine in calves.
    Chaudhary RK; Srivastava AK
    Br Vet J; 1989; 145(4):389-93. PubMed ID: 2775988
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pharmacokinetic study of cefsulodin in children].
    Ikeda Y; Higashijima T; Oguchi Y; Okumura K; Ozeki M; Okada A
    Jpn J Antibiot; 1985 Jan; 38(1):145-54. PubMed ID: 3989975
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pharmacokinetics of cephaloridine in the human organism during its intravenous administration].
    Dvorácek K; Modr Z; Grafnetterová J; Bláha V; Necásková A
    Cas Lek Cesk; 1969 Feb; 108(9):258-63. PubMed ID: 5779475
    [No Abstract]   [Full Text] [Related]  

  • 30. [Cephaloridine. Clinical study on 100 cases].
    Rechniewsky C; Gherardi CR; Mazzei CM; Diez E
    Prensa Med Argent; 1968 Mar; 55(4):187-93. PubMed ID: 5741630
    [No Abstract]   [Full Text] [Related]  

  • 31. [Study on administration method of dibekacin].
    Soejima R; Tano Y; Niki Y; Katoh O
    Jpn J Antibiot; 1982 Dec; 35(12):2768-72. PubMed ID: 7182532
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pharmacodynamics of cephaloridine and cephalothin combined with sulfalene in rabbits].
    Bobrov VI; Beletskaia GT; Iakovlev VP
    Antibiotiki; 1984 Nov; 29(11):823-5. PubMed ID: 6524880
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pharmacokinetics in neonates and infants following administration of amikacin].
    Iwai N; Sasaki A; Taneda Y; Mizoguchi F; Nakamura H; Kawamura M; Tauchi N; Ozaki T; Ichikawa T; Matsui S
    Jpn J Antibiot; 1987 Jun; 40(6):1157-75. PubMed ID: 3669298
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cephaloridine.
    Mandell GL
    Ann Intern Med; 1973 Oct; 79(4):561-5. PubMed ID: 4748274
    [No Abstract]   [Full Text] [Related]  

  • 35. [Clinical studies on tobramycin using intravenous drip infusion (author's transl)].
    Saito A; Kikuiri T; Tomizawa M; Ujiie A; Kinoshita Y
    Jpn J Antibiot; 1981 Sep; 34(9):1255-62. PubMed ID: 7328750
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Absorption, excretion and distribution of amikacin following intravenous drip infusion. Intravenous drip infusion, one shot intravenous injection and intramuscular administration of amikacin in dogs, rabbits and rats].
    Matsumoto H; Ochiai K; Nakajima A; Matsuzaki M
    Jpn J Antibiot; 1982 Aug; 35(8):2034-46. PubMed ID: 7154249
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Basic studies of cefotiam (author's transl)].
    Aoyama T
    Jpn J Antibiot; 1982 Mar; 35(3):801-6. PubMed ID: 6285016
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical studies on amikacin for infectious diseases following intravenous drip infusion (author's transl)].
    Nakamura T; Hashimoto I; Sawada Y; Mikami J; Saitoh M; Hattanda K; Bekki E; Nishidai H; Nakanishi M; Kasai Y
    Jpn J Antibiot; 1982 Apr; 35(4):897-908. PubMed ID: 7097987
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical evaluation of amikacin in severe infections with hematological malignant diseases (author's transl)].
    Hotta T; Hirabayashi N; Shimizu K; Utsumi M; Katoh T; Maeda H; Hirano A; Ohnishi K; Murate T; Yamada H
    Jpn J Antibiot; 1981 Nov; 34(11):1457-64. PubMed ID: 7334580
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cephaloridine serum levels after intravenous injection.
    Mathews DD
    J Antimicrob Chemother; 1975; 1(3 Suppl):37-40. PubMed ID: 1201980
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.